TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 259 participants.
Also called NCT03357874
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 259 participants
- Registry
-
NCT03357874 -
2017-002839-42
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT03357874. Randomized; no masking; primary purpose treatment. Start 2018-10-28 (actual); primary completion 2023-01-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
- Acronym
- TROUPER
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
Record details
- Record id
cardio:ct-nct03357874- Content hash
2604a12c727da0f974549cb253f553a7462939ec155a3056f520dab66ea2ebc9